Cargando…

Immune profiling of breast cancer patients: relationship between tumour antigen T cell responses with suppressor and effector leukocyte populations

Detalles Bibliográficos
Autores principales:	Janssen, Nicole, Pawelec, Graham, Speigl, Lisa, Fortis, Sotirios P, Haritos, Christoforos, Perez, Sonia A, Baxevanis, Constantin N, Bailur, Jithendra Kini, Shipp, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649285/ http://dx.doi.org/10.1186/2051-1426-3-S2-P264

Ejemplares similares

Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients
por: Bailur, Jithendra Kini, et al.
Publicado: (2015)

Linking tumor with systemic environment in the search for novel biomarkers in breast cancer
por: Fortis, Sotirios P, et al.
Publicado: (2015)

Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer
por: Kini Bailur, Jithendra, et al.
Publicado: (2016)

Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
por: Fortis, Sotirios P., et al.
Publicado: (2017)

Presence of circulating Her-2 reactive CD8 T cells is associated with a lower frequency of MDSCs and better survival in elderly breast cancer patients
por: Kini Bailur, Jithendra, et al.
Publicado: (2014)

Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients
por: Bailur, Jithendra Kini, et al.
Publicado: (2015)

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty
por: Bailur, Jithendra Kini, et al.
Publicado: (2017)

Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design
por: Baxevanis, Constantin N., et al.
Publicado: (2020)

The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
por: Stokidis, Savvas, et al.
Publicado: (2023)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

The thin red line between the immune system and cancer evolution
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
por: Stokidis, Savvas, et al.
Publicado: (2020)

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine
por: Anastasopoulou, Eleftheria A, et al.
Publicado: (2015)

Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
por: Fortis, Sotirios P., et al.
Publicado: (2022)

Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen
por: Hickey, Michelle J., et al.
Publicado: (2016)

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
por: Thomaidou, Arsinoe C., et al.
Publicado: (2022)

Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer
por: Goulielmaki, Maria, et al.
Publicado: (2023)

Effect of Culture at Low Oxygen Tension on the Expression of Heat Shock Proteins in a Panel of Melanoma Cell Lines
por: Shipp, Christopher, et al.
Publicado: (2012)

A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2023)

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
por: Brouwers, Barbara, et al.
Publicado: (2016)

Radiotherapy-Related Gene Signature in Prostate Cancer
por: Fortis, Sotirios P., et al.
Publicado: (2022)

T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
por: Papalouka, Chara, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay
por: Koukourakis, Michael I., et al.
Publicado: (2023)

Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
por: Baxevanis, C. N., et al.
Publicado: (1994)

Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032
por: Kogionou, Paraskevi, et al.
Publicado: (2023)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019)

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.
por: Ferrarini, M., et al.
Publicado: (1990)

Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State
por: Baxevanis, Constantin N., et al.
Publicado: (2015)

Endogenous immunity at the forefront of tumor dormancy
por: Baxevanis, Constantin N, et al.
Publicado: (2015)

An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
por: Rovillain, Emilie, et al.
Publicado: (2011)

Enhanced Chemokine Receptor Expression on Leukocytes of Patients with Alzheimer's Disease
por: Goldeck, David, et al.
Publicado: (2013)

Monitoring Phosphoinositide Fluxes and Effectors During Leukocyte Chemotaxis and Phagocytosis
por: Montaño-Rendón, Fernando, et al.
Publicado: (2021)

The impact of radiation therapy on the TCR Vβ chain repertoire in patients with prostate cancer
por: Goulielmaki, Maria, et al.
Publicado: (2022)

Tinker, Tailor, Tumour Suppressor: The Many Functions of PRP4K
por: Habib, Elias B., et al.
Publicado: (2022)

Human Leukocyte Antigens in Pregnancy and Preeclampsia
por: Aisagbonhi, Omonigho, et al.
Publicado: (2022)

ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
por: Baxevanis, Constantin N.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dgfce9dorgq51apme1j79i22ug